CRISPR Therapeutics Ltd header image

CRISPR Therapeutics Ltd

CRSP

Equity

ISIN CH0334081137 / Valor 33408113

NASDAQ (2024-11-08)
USD 51.62-0.50%

CRISPR Therapeutics Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

CRISPR Therapeutics Ltd is a biotechnology company that focuses on developing gene-editing therapies. One of their key products is CASGEVY™, a CRISPR/Cas9 gene-edited therapy developed in collaboration with Vertex Pharmaceuticals Incorporated, which has received approval in some countries for treating patients with sickle cell disease or transfusion-dependent beta thalassemia. The company's innovative approach to gene editing has the potential to revolutionize the treatment of genetic diseases, offering hope to patients with previously untreatable conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-5.67%1Y
-45.2%3Y
2.14%5Y

Performance

57.9%1Y
61.1%3Y
62.1%5Y

Volatility

Market cap

4592 M

Market cap (USD)

Daily traded volume (Shares)

435,610

Daily traded volume (Shares)

1 day high/low

53 / 51.15

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Paul Hartmann AG
Paul Hartmann AG Paul Hartmann AG Valor: 1547181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 196.50
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%EUR 124.85
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%CHF 81.02
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.33%CHF 76.25
medmix Ltd
medmix Ltd medmix Ltd Valor: 112967710
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.51%CHF 9.71
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.31%SEK 295.50
Medicover AB
Medicover AB Medicover AB Valor: 36765439
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.05%SEK 179.00
Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.19%EUR 25.54
Formycon AG
Formycon AG Formycon AG Valor: 12194189
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.17%EUR 47.30
RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.67%EUR 12.20